SCHEMBL9960971

SCHEMBL9960971

COc1cc(C2=C(c3cn(C(C)C(CC(C)C)(NC(=O)OC(C)(C)C)C(=O)O)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.53
GSK3B P49841 12/20 0.53
FLT3 P36888 10/20 0.53
PLK4 O00444 4/20 0.44
AURKA O14965 4/20 0.44
FLT4 P35916 4/20 0.44
TEK Q02763 4/20 0.44
PDGFRB P09619 3/20 0.44
SRC P12931 3/20 0.44
PTK2 Q05397 3/20 0.44
EGFR P00533 2/20 0.44
ERBB2 P04626 2/20 0.44
INSR P06213 2/20 0.44
IGF1R P08069 2/20 0.44
MET P08581 2/20 0.44
CDK4 P11802 2/20 0.44
BRAF P15056 2/20 0.44
CCND1 P24385 2/20 0.44
CDK2 P24941 2/20 0.44
EPHB4 P54760 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19056963 0.91 KDR (0.44) KDRGSK3BFLT3PLK4AURKA
SCHEMBL9960974 0.83 KDR (0.61) KDRGSK3BFLT3PLK4AURKA
SCHEMBL9960975 0.80 KDR (0.50) KDRGSK3BFLT3PLK4AURKA
SCHEMBL10070115 0.77 KDR (0.73) KDRGSK3BFLT3PLK4AURKA
SCHEMBL10070114 0.76 GSK3B (0.73) KDRGSK3BFLT3PLK4AURKA
SCHEMBL19056960 0.75 KDR (0.49) KDRGSK3BFLT3PLK4AURKA
SCHEMBL10070566 0.75 GSK3B (0.75) KDRGSK3BFLT3PLK4AURKA
SCHEMBL9960978 0.74 GSK3B (0.61) KDRGSK3BFLT3PLK4AURKA
SCHEMBL19056964 0.74 GSK3B (0.49) KDRGSK3BFLT3PLK4AURKA
SCHEMBL10070111 0.73 GSK3B (0.68) KDRGSK3BFLT3PLK4AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655359-A1 CONJUGATED 3-(INDOLYL)- AND 3-(AZAINDOLYL)-4-ARYLMALEIMIDE COMPOUNDS AND THEIR USE IN TUMOR TREATMENT Johannes-Gutenberg-Universität Mainz (DE) 2013-10-30 EP disclosed
WO-2012084683-A1 CONJUGATED 3-(INDOLYL)- AND 3-(AZAINDOLYL)-4-ARYLMALEIMIDE COMPOUNDS AND THEIR USE IN TUMOR TREATMENT Johannes Gutenberg-Universität Mainz (DE) 2012-06-28 WO disclosed